Cargando…

Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy

Objective. To assess the effectiveness of recombinant human thrombopoietin (rhTPO) in severe aplastic anemia (SAA) patients receiving immunosuppressive therapy (IST). Methods. Eighty-eight SAA patients receiving IST from January 2007 to December 2012 were included in this retrospective analysis. Of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huaquan, Dong, Qi'e, Fu, Rong, Qu, Wen, Ruan, Erbao, Wang, Guojin, Liu, Hong, Wu, Yuhong, Song, Jia, Xing, Limin, Guan, Jing, Li, Lijuan, Shao, Zonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377357/ https://www.ncbi.nlm.nih.gov/pubmed/25861635 http://dx.doi.org/10.1155/2015/597293

Ejemplares similares

A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy
por: Guan, Jing, et al.
Publicado: (2019)

De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017)

Granulocyte Transfusion Combined with Granulocyte Colony Stimulating Factor in Severe Infection Patients with Severe Aplastic Anemia: A Single Center Experience from China
por: Wang, Huaquan, et al.
Publicado: (2014)

The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China
por: Wang, Huaquan, et al.
Publicado: (2014)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
por: Zhang, Mengying, et al.
Publicado: (2023)

Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report
por: Niu, Haiyue, et al.
Publicado: (2020)

Abnormal expression of histone acetylases in CD8+ T cells of patients with severe aplastic anemia
por: Qi, Weiwei, et al.
Publicado: (2022)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

P1353: EXPLORING A NOVEL TREATMENT STRATEGY FOR ACQUIRED APLASTIC ANEMIA TARGETING PPAR SIGNALING PATHWAY.
por: Yang, Liping, et al.
Publicado: (2023)

Abnormal Proteomics Profile of Plasma Reveals the Immunological Pathogenesis of Severe Aplastic Anemia
por: Qi, Weiwei, et al.
Publicado: (2022)

Myeloid dendritic cells in severe aplastic anemia patients exhibit stronger phagocytosis
por: Sun, Yingying, et al.
Publicado: (2021)

APC/C is essential for hematopoiesis and impaired in aplastic anemia
por: Wang, Jia, et al.
Publicado: (2017)

Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia
por: Qi, Weiwei, et al.
Publicado: (2015)

Aplastic anemia: immunosuppressive therapy in 2010
por: Risitano, Antonio M., et al.
Publicado: (2011)

PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia
por: Liu, Chunyan, et al.
Publicado: (2018)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012)

Effects of Shikonin on the Functions of Myeloid Dendritic Cells in a Mouse Model of Severe Aplastic Anemia
por: Zheng, Mengying, et al.
Publicado: (2020)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
por: Yıldırmak, Yıldız, et al.
Publicado: (2012)

Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease
por: Fu, Rong, et al.
Publicado: (2014)

Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function
por: Chen, Jin, et al.
Publicado: (2019)

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
por: Rogers, Zora R., et al.
Publicado: (2019)

Thrombopoietin and its receptor in normal and neoplastic hematopoiesis
por: Kaushansky, Kenneth
Publicado: (2016)

Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity
por: Singh, Abhay, et al.
Publicado: (2015)

Upregulated expression of leukocyte immunoglobulin-like receptor A3 in patients with severe aplastic anemia
por: Yu, Hong, et al.
Publicado: (2021)

Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease
por: Wang, Huaquan, et al.
Publicado: (2023)

Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag
por: Zaimoku, Yoshitaka, et al.
Publicado: (2021)

Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
por: Zhao, Yufei, et al.
Publicado: (2023)

Cofilin‐1 participates in the hyperfunction of myeloid dendritic cells in patients with severe aplastic anaemia
por: Sun, Yingying, et al.
Publicado: (2022)

The shortening telomere length of T lymphocytes maybe associated with hyper-function in servere aplastic anemia
por: Wang, Chaomeng, et al.
Publicado: (2018)

Thymoma followed by aplastic anemia - two different responses to immunosuppressive therapy
por: de Castro, Murilo Antunes, et al.
Publicado: (2011)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
por: Chen, Hai-Fei, et al.
Publicado: (2014)

Infection risk in autoimmune hematological disorders with low‐dose rituximab treatment
por: Wang, Honglei, et al.
Publicado: (2020)

Plasma Metabolomic and Intestinal Microbial Analyses of Patients With Severe Aplastic Anemia
por: Shao, Yuanyuan, et al.
Publicado: (2021)

Identification of potential pathogenic genes for severe aplastic anemia by whole‐exome sequencing
por: Zhang, Yang, et al.
Publicado: (2022)

Acquired aplastic anemia: Is bystander insult to autologous hematopoiesis driven by immune surveillance against malignant cells?
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

P761: UMBILICAL CORD BLOOD ORIGIN CELLS RECONSTRUCT THE HEMATOPOIESIS OF APLASTIC ANEMIA ANIMAL MODEL
por: Chen, Zesong, et al.
Publicado: (2023)

Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia
por: Chen, Cunte, et al.
Publicado: (2023)

Immunosuppressive Therapy in Patients with Aplastic Anemia: A Single-Center Retrospective Study
por: Jalaeikhoo, Hasan, et al.
Publicado: (2015)

PB1932: GENERIC ELTHROMBOPAG WITH STANDARD IMMUNOSUPPRESSIVE THERAPY IN SEVERE APLASTIC ANEMIA
por: Ranjit Kumar, C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b33vt5o98t136f4c65993pmrnf